Pulse Data, Inc. announced it raised $16.5 Million in an initial filing from an offering of $16.5 Million

Company

Location

About

pulseData uses patented AI to better diagnose, risk stratify and predict adverse events for patients with chronic kidney disease or disorders involving both the heart and the kidneys. Our software drives preventive action, saves medical costs and helps eliminate suffering and we’re on a mission to help eliminate preventable sickness.